Back to Top Skip to main content Skip to sub-navigation

Air Force bioenvironmental engineers expand mission in aerovac, workspaces

Military Captain and team cleaning large, plastic enclosed space U.S Air Force Capt. Naomi King, 628th Operational Medical Readiness Squadron infectious disease team lead, reviews COVID-19 cleaning procedures with Airmen in the Transport Isolation System at Joint Base Charleston, South Carolina, April 5, 2020. The TIS is an infectious disease containment unit designed to minimize risk to aircrew and medical attendants, while allowing in-flight medical care for patients affected by contagions like COVID-19. (U.S. Air Force photo by Senior Airman Allison Payne)

Recommended Content:

Coronavirus | Public Health

FALLS CHURCH, Va. -- Bioenvironmental engineers across the Air Force are working to keep the workplace safe during the COVID-19 pandemic.

Col. Brian Peake, Air Force Bioenvironmental Engineering associate corps chief, says bioenvironmental engineers are using their experience in exposures and risk mitigation to combat the spread of the disease.

“Bioenvironmental engineers can take our knowledge of exposure science and apply it to any environmental threat, like COVID-19,” said Peake. “We can take what we have done for decades to mitigate Airmen exposure.”

The aeromedical evacuation mission became a top priority as COVID-19 began to spread.

Bioenvironmental engineers within Air Mobility Command lent their expertise in exposure mitigation when the Air Force was tasked with moving COVID-19 patients.

The Air Force is using the Transportation Isolation System, which was created in 2014 during the Ebola epidemic, and adapted to move COVID-19 patients. The Transportation Isolation System is an infectious disease containment unit that fits inside cargo aircraft and reduces risk to aircrew while allowing for en route medical care.

A cross functional team led by Master Sgt. Michael Huller, AMC Bioenvironmental Engineer functional manager, constructed a disinfection concept of operations and training plan in only ten days in advance of the first mission.

“Prior to the COVID-19 pandemic, there were only a handful of people trained on Transportation Isolation System support,” said Col. Vincent Falls, Command Bioenvironmental Engineer, Air Mobility Command. “To expand this capability to move more patients, we had to develop plans to project this capability to multiple locations, and come up with procedures to properly disinfect and reuse the TIS.”

On April 10, the Air Force used the Transportation Isolation System for the first time to move three COVID-19 patients from Afghanistan. Bioenvironmental engineers were on the flight, working alongside aeromedical evacuation crews and critical care air transportation teams.

“As part of that Transportation Isolation System support team, we ensured it maintained its integrity, and diagnosed and fixed any issues that arose in flight,” said Maj. Somvang Xayarath, Deputy Command Bioenvironmental Engineer with AMC and the bioenvironmental engineer on the first mission.

Xayarath played a key role in the support planning. He ensured everything on the aircraft was disinfected properly after the mission, and helped the follow-on support team prepare the next mission.

After that first mission, AMC deployed 42 bioenvironmental engineer technicians to Joint Base Charleston, South Carolina, in preparation for additional missions across the globe.

“Aeromedical evacuation is usually not a primary mission for bioenvironmental engineers,” said Huller. “Because we are skilled in doing health risk assessments, industrial operations, and hygiene plans, we can transition and operate in this arena.”

The bioenvironmental engineers’ involvement in safely moving COVID-19 patients highlights their flexibility, applying their skillset and foundational knowledge to new and emerging threats.

“We always talk about every Airman a problem solver,” said Huller. “As bioenvironmental engineers, we are a career field of problem solvers. We were tasked with adapting one system originally designed to move Ebola patients for a new use, and we did that in ten days.”

Because there is a large aerosol hazard with COVID-19, bioenvironmental engineers are also considering how this impacts Airmen in otherwise safe workspaces where respiratory exposures are not usually hazardous. Bioenvironmental engineers are ensuring N95 masks are properly tested to meet regulatory requirements, and identifying ways workspaces can be made safer.

“We ensure N95 masks meet the U.S. Department of Labor’s Occupational Safety and Health Administration guidelines,” said Falls. “We make sure that these masks are fit tested, that it has an appropriate seal on the user’s face, and that it works properly.”

To further safeguard Airmen, bioenvironmental engineers are also considering the use of high-efficiency particulate air filtration, or HEPA filtration. Bioenvironmental engineers are leading an initiative to develop filtration capability where it would be most effective.

“We usually take for granted that the air we breathe is safe,” said Peake. “COVID-19 puts us in new territory where we have to figure out ways we can protect Airmen working in tight quarters.”

From aeromedical evacuation, to air filtration and mask checks, bioenvironmental engineers are working around the clock to keep Airmen safe and the Air Force mission going.

“Bioenvironmental engineers provide highly reliable health risk expertise to protect Airmen from workplace hazards and ensure their readiness to support the mission,” said Chief Master Sgt. Curtis McGehee, Air Force Bioenvironmental Engineering career field manager. “That is normal operations for us and we are applying this process to keep Airmen safe amid the COVID-19 pandemic.”

Disclaimer: Re-published content may be edited for length and clarity.  Read original post.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

Access to Medical Services Who were Exposed to Rabies in Combat Theater

Policy

U.S. Navy/U.S. Marine Corps COSC Policy Update

Policy
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.